    <SEC-DOCUMENT>0001193125-25-098525-index.html : 20250428
    <SEC-HEADER>0001193125-25-098525.hdr.sgml : 20250428
    <ACCEPTANCE-DATETIME>20250428082329
    ACCESSION NUMBER:		0001193125-25-098525
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20241231
    FILED AS OF DATE:		20250428
    DATE AS OF CHANGE:		20250428
    EFFECTIVENESS DATE:		20250428

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Akero Therapeutics, Inc.
    		CENTRAL INDEX KEY:			0001744659
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		EIN:				000000000
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-38944
    		FILM NUMBER:		25876056

    	BUSINESS ADDRESS:
    		STREET 1:		601 GATEWAY BOULEVARD, SUITE 350
    		CITY:			SOUTH SAN FRANCISCO
    		STATE:			CA
    		ZIP:			94080
    		BUSINESS PHONE:		650-487-6488

    	MAIL ADDRESS:
    		STREET 1:		601 GATEWAY BOULEVARD, SUITE 350
    		CITY:			SOUTH SAN FRANCISCO
    		STATE:			CA
    		ZIP:			94080
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>d783418dars.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: d783418dars.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>